 | The topic of this article may not meet Wikipedia's
general notability guideline. (May 2017) |
Align Biopharma is an initiative by six of the largest global pharmaceutical companies to create standards for physicians to access information on drugs. [1]
The companies participating include Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis and Pfizer, and the software company Veeva Systems. The group is led by vice presidents and technology officers from each participating company. [2]
It was created to address the expansion of personalized medicine and specialized drugs, which are not frequently prescribed and tailored prescribing information is needed for each patient. The stated goals of Align are to allow physicians to use a single login to access pharmaceutical information for all six companies, and create a standard for consenting to receive information from pharmaceutical companies. [3] Currently, companies individually verify the health care credentials of each provider before allowing them access to information. [4] [5]
References
- ^ "Top Global Pharma Companies Establish New Industry Standards Group". Business Wire. 2017-01-11. Retrieved 2017-05-22.
- ^ Veeva Systems. "About". Align Biopharma. Retrieved 2017-05-22.
- ^ "Gigya is Newest Member of Industry Standards Group, Align Biopharma". GlobeNewswire News Room. 2017-07-13. Retrieved 2024-04-19.
- ^ "Novartis, Pfizer join with Big Biopharma peers to create tech standards that streamline how HCPs access info". FierceBiotech. Retrieved 2017-05-22.
- ^ "Pharma's latest idea for getting drug info in front of docs? Give them a single login".
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |